Source: New feed
Novartis, Verily back $300M Medicxi biotech growth fund ...
Novartis and Verily have helped Medicxi raise $300 million (€268 million) to invest in late-stage drug developers. The fund sees Medicxi move beyond its ...
UK-based VC Launches Massive $300M Fund to Fill Gap for Late-Stage BiotechLabiotech.eu (blog)
Alphabet's Verily Invests In $300 Million EU Biotech FundAndroid Headlines
Alphabet throws weight behind $300m European biotech fundThe New Economy
pharmaphorum -Genetic Engineering & Biotechnology News
all 17 news articles »